Jiangsu Hengrui Medicine Co., Ltd. (SHA: 600276)

Jiangsu Hengrui Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22,312	20,746	15,111	13,631	10,805	5,044
Trading Asset Securities	973.23	99.05	2,760	5,090	5,628	8,520
Cash & Short-Term Investments	23,285	20,845	17,871	18,721	16,433	13,563
Cash Growth	37.30%	16.64%	-4.54%	13.93%	21.15%	248.70%
Accounts Receivable	6,932	6,135	8,341	6,884	8,176	5,435
Other Receivables	390.46	438.25	562.18	658	651.15	982.05
Receivables	7,322	6,573	8,904	7,542	8,827	6,417
Inventory	2,252	2,314	2,451	2,403	1,778	1,607
Prepaid Expenses	237.12	226.07	507.2	431.57	410.18	86.07
Other Current Assets	1,680	1,329	1,201	1,090	602.25	638.13
Total Current Assets	34,777	31,287	30,934	30,188	28,050	22,311
Property, Plant & Equipment	6,634	6,629	6,676	6,276	4,585	4,075
Long-Term Investments	1,499	1,451	1,508	1,001	1,502	599.43
Other Intangible Assets	861.91	883.77	519.9	442.45	341.25	349.76
Long-Term Deferred Tax Assets	404.34	320.56	238.9	141.36	52.97	66.09
Long-Term Deferred Charges	3,613	2,829	2,052	569.38	197.63	155.09
Other Long-Term Assets	392.45	383.3	442.55	648.99	-	-
Total Assets	48,181	43,785	42,371	39,266	34,730	27,556
Accounts Payable	1,325	1,334	1,493	1,920	1,151	1,289
Accrued Expenses	122.33	139.95	97.57	165.66	130.54	185.29
Short-Term Debt	-	-	1,261	-	-	-
Current Income Taxes Payable	112.05	59.28	4.03	21.77	25.14	17.75
Current Unearned Revenue	1,226	198.09	187.08	219.55	358.06	222.64
Other Current Liabilities	1,987	822.32	596.13	1,074	2,107	757.7
Total Current Liabilities	4,808	2,554	3,639	3,402	3,772	2,473
Long-Term Leases	58.28	75.18	98.86	151.59	-	-
Long-Term Unearned Revenue	42.55	38.95	119.44	116.52	141.24	122.22
Long-Term Deferred Tax Liabilities	85.09	83.64	100.45	24.77	29.76	24.09
Total Liabilities	4,994	2,751	3,958	3,694	3,943	2,619
Common Stock	6,379	6,379	6,379	6,396	5,332	4,423
Additional Paid-In Capital	3,167	3,058	3,020	3,356	3,143	1,663
Retained Earnings	34,260	32,102	28,819	25,928	23,530	19,103
Treasury Stock	-1,202	-1,092	-398.03	-664.94	-1,495	-419.84
Comprensive Income & Other	18.55	19.32	3.23	-12.16	-4.79	6.53
Total Common Equity	42,622	40,466	37,824	35,003	30,504	24,775
Minority Interest	564.89	567.29	589.35	568.85	282.7	162.2
Shareholders' Equity	43,187	41,033	38,413	35,572	30,787	24,938
Total Liabilities & Equity	48,181	43,785	42,371	39,266	34,730	27,556
Total Debt	95.02	75.18	1,360	151.59	-	-
Net Cash (Debt)	23,190	20,770	16,511	18,570	16,433	13,563
Net Cash Growth	37.44%	25.79%	-11.08%	13.00%	21.15%	248.70%
Net Cash Per Share	3.68	3.28	2.58	2.91	2.57	2.12
Filing Date Shares Outstanding	6,191	6,361	6,367	6,382	6,355	6,342
Total Common Shares Outstanding	6,191	6,361	6,367	6,382	6,355	6,342
Working Capital	29,968	28,734	27,295	26,786	24,278	19,839
Book Value Per Share	6.88	6.36	5.94	5.48	4.80	3.91
Tangible Book Value	41,760	39,582	37,304	34,561	30,163	24,426
Tangible Book Value Per Share	6.74	6.22	5.86	5.42	4.75	3.85
Buildings	3,899	3,854	3,541	2,700	2,141	1,720
Machinery	6,086	5,969	5,684	5,120	4,063	3,395
Construction In Progress	1,142	1,101	1,193	1,659	1,305	1,533

Source: S&P Capital IQ. Standard template. Financial Sources.